Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors
- Resource Type
- Article
- Source
- In
BBA - Molecular Basis of Disease June 2023 1869(5) - Subject
- Language
- ISSN
- 0925-4439